+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Gene Type (Standard v/s Complex), By Product Type (Cloning Kits v/s Mutagenesis Kits), By Technique, By Application, By End User, By Region and Competition

  • PDF Icon

    Report

  • 119 Pages
  • March 2023
  • Region: Global
  • TechSci Research
  • ID: 5768468
Free Webex Call
10% Free customization
Description Jump to:

Various New Product Launches in the Cloning and Mutagenesis Market, Which Will Demand Cloning and Mutagenesis Kits, Along with Government Organizations Investing in Stem Cell Research for the Development of New Treatments and Therapy, Have Significantly Increased the Demand for Cloning and Mutagenes

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

 10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Cloning & Mutagenesis Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing cloning approaches in different genetic applications like reproductive cloning and genetic cloning. Additionally, various new product launches in the cloning and mutagenesis market, which will demand cloning and mutagenesis kits, along with government organizations investing in stem cell research for the development of new treatments and therapy, have significantly increased the demand for cloning and mutagenesis across different parts of the globe. Additionally, the growing geriatric population across the globe, which is susceptible to different kinds of diseases and obesity, is further expected to increase the demand for cloning and mutagenesis, thereby fuelling market growth through 2028. Besides, growing awareness about the advantages of using gene therapy and diagnosis, along with increasing healthcare expenditure on chronic disease treatment across the globe, are further expected to support the cloning and mutagenesis market during the forecast period. In 2022, an estimated 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in the United States.

Increasing Research and Development Activities in Cancer and Other Chronic Disorders Fueling the Market Growth

Increasing research and development regarding cloning and mutagenesis for the development of cancer therapies and other rare disorders is expected to create lucrative growth in the market during the forecast period. Government organizations are focusing on developed infrastructure with higher profits. Different types of innovative and ethically accepted therapies available for cancer therapy, along with the increasing development of new products, are expected to boost market growth over the years. In May 2020, Takara Bio announced a collaboration with AGC Biologics, and their businesses would collaborate on a prophylactic DNA vaccine against COVID-19 with AGC Biologics manufacturing the plasmid DNA intermediate for the vaccine. . as public-funded research is getting a boost from bodies such as the European Commission and the Japan Agency for Medical Research and Development. In 2020, an estimated 276,480 new cases of invasive breast cancer will be diagnosed in women in the U.S. as well as 48,530 new cases of non-invasive (in situ) breast cancer. The increasing cloning of genes for the synthesis of antibiotics, hormones, and vitamins, among others, for the treatment of issues such as cystic fibrosis is propelling the market growth.

Increasing Investment by Government Organizations is Driving the Market Growth

Important factors which are expected to create lucrative growth in the market include a favorable funding scenario for gene synthesis and cloning services, along with technological advancement in the treatment, followed by research, subcloning services, and rising synergistic activities in the market. Increasing demand for gene therapy and growing adoption of novel and advanced DNA cloning technologies are expected to create a lucrative growth of the market during the forecast period.

Market Segmentation

Global cloning & mutagenesis market can be segmented by gene type, product type, technique, application, end-user, and by region. Based on gene type, the market can be divided into Standard and Complex. Based on product type, the market can be divided into Cloning Kits and Mutagenesis Kits. Based on technique, the market can be segmented into Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-Directed Mutagenesis, and Others. Based on application, the market can be segmented into Gene Synthesis, Gene Expression, Gene Therapy, Vaccine Research, and Others. Based on the end user, the market can be differentiated into Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America.

Market Players

Agilent Technologies, Inc., Eurofins Scientific SE, Sartorius AG, Collecta, Inc., Codex DNA Inc., Lonza Group AG, Charles River Laboratories International, Inc., TransGene Biotech Co. Ltd., Takara Bio, Inc., Thermo Fisher Scientific Inc. are some of the leading players operating in the Global Cloning & Mutagenesis Market.

Recent Development

  • In Jan 2021, Codex DNA and Pfizer signed an early access collaboration and licensing agreement, which will allow Pfizer to use CodexDNA's novel enzymatic DNA synthesis technology in its research and development of mRNA-based vaccines and biotherapies and it will be responsible for further developing the technology.
  • In May 2020, GenScript just launched a GMP single-strand and double-strand DNA service to aid in the growth of gene and cell therapies. The announcement highlights GenScript's commitment to assisting entire non-viral cell therapy development through the IND-enabling and clinical stages.

Report Scope:

In this report, global cloning & mutagenesis market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Cloning & Mutagenesis Market, By Gene Type:

  • Standard
  • Complex

Cloning & Mutagenesis Market, By Product Type:

  • Cloning Kits
  • Mutagenesis Kits

Cloning & Mutagenesis Market, By Technique:

  • Topo PCR Cloning
  • Blunt End Cloning
  • Seamless Cloning
  • Site-Directed Mutagenesis
  • Others

Cloning & Mutagenesis Market, By Application:

  • Gene Synthesis
  • Gene Expression
  • Gene Therapy
  • Vaccine Research
  • Others

Cloning & Mutagenesis Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions
  • Others

Cloning & Mutagenesis Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive landscape

Company Profiles: Detailed analysis of the major companies present in Global Cloning & Mutagenesis Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cloning & Mutagenesis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Gene Type (Standard v/s Complex)
5.2.2. By Product Type (Cloning Kits v/s Mutagenesis Kits)
5.2.3. By Technique (Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-Directed Mutagenesis, Others)
5.2.4. By Application (Gene Synthesis, Gene Expression, Gene Therapy, Vaccine Research, Others)
5.2.5. By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)
5.2.6. By Region
5.2.7. By Company (2022)
5.3. Market Map
5.3.1. By Gene Type
5.3.2. By Product Type
5.3.3. By Technique
5.3.4. By Application
5.3.5. By End User
5.3.6. By Region
6. North America Cloning & Mutagenesis Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Gene Type
6.2.2. By Product Type
6.2.3. By Technique
6.2.4. By Application
6.2.5. By End User
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Cloning & Mutagenesis Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Gene Type
6.3.1.2.2. By Product Type
6.3.1.2.3. By Technique
6.3.1.2.4. By Application
6.3.1.2.5. By End User
6.3.2. Canada Cloning & Mutagenesis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Gene Type
6.3.2.2.2. By Product Type
6.3.2.2.3. By Technique
6.3.2.2.4. By Application
6.3.2.2.5. By End User
6.3.3. Mexico Cloning & Mutagenesis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Gene Type
6.3.3.2.2. By Product Type
6.3.3.2.3. By Technique
6.3.3.2.4. By Application
6.3.3.2.5. By End User
7. Europe Cloning & Mutagenesis Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Gene Type
7.2.2. By Product Type
7.2.3. By Technique
7.2.4. By Application
7.2.5. By End User
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Cloning & Mutagenesis Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Gene Type
7.3.1.2.2. By Product Type
7.3.1.2.3. By Technique
7.3.1.2.4. By Application
7.3.1.2.5. By End User
7.3.2. Germany Cloning & Mutagenesis Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Gene Type
7.3.2.2.2. By Product Type
7.3.2.2.3. By Technique
7.3.2.2.4. By Application
7.3.2.2.5. By End User
7.3.3. United Kingdom Cloning & Mutagenesis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Gene Type
7.3.3.2.2. By Product Type
7.3.3.2.3. By Technique
7.3.3.2.4. By Application
7.3.3.2.5. By End User
7.3.4. Italy Cloning & Mutagenesis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Gene Type
7.3.4.2.2. By Product Type
7.3.4.2.3. By Technique
7.3.4.2.4. By Application
7.3.4.2.5. By End User
7.3.5. Spain Cloning & Mutagenesis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Gene Type
7.3.5.2.2. By Product Type
7.3.5.2.3. By Technique
7.3.5.2.4. By Application
7.3.5.2.5. By End User
8. Asia-Pacific Cloning & Mutagenesis Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Gene Type
8.2.2. By Product Type
8.2.3. By Technique
8.2.4. By Application
8.2.5. By End User
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Cloning & Mutagenesis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Gene Type
8.3.1.2.2. By Product Type
8.3.1.2.3. By Technique
8.3.1.2.4. By Application
8.3.1.2.5. By End User
8.3.2. India Cloning & Mutagenesis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Gene Type
8.3.2.2.2. By Product Type
8.3.2.2.3. By Technique
8.3.2.2.4. By Application
8.3.2.2.5. By End User
8.3.3. Japan Cloning & Mutagenesis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Gene Type
8.3.3.2.2. By Product Type
8.3.3.2.3. By Technique
8.3.3.2.4. By Application
8.3.3.2.5. By End User
8.3.4. South Korea Cloning & Mutagenesis Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Gene Type
8.3.4.2.2. By Product Type
8.3.4.2.3. By Technique
8.3.4.2.4. By Application
8.3.4.2.5. By End User
8.3.5. Australia Cloning & Mutagenesis Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Gene Type
8.3.5.2.2. By Product Type
8.3.5.2.3. By Technique
8.3.5.2.4. By Application
8.3.5.2.5. By End User
9. South America Cloning & Mutagenesis Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Gene Type
9.2.2. By Product Type
9.2.3. By Technique
9.2.4. By Application
9.2.5. By End User
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Cloning & Mutagenesis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Gene Type
9.3.1.2.2. By Product Type
9.3.1.2.3. By Technique
9.3.1.2.4. By Application
9.3.1.2.5. By End User
9.3.2. Argentina Cloning & Mutagenesis Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Gene Type
9.3.2.2.2. By Product Type
9.3.2.2.3. By Technique
9.3.2.2.4. By Application
9.3.2.2.5. By End User
9.3.3. Colombia Cloning & Mutagenesis Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Gene Type
9.3.3.2.2. By Product Type
9.3.3.2.3. By Technique
9.3.3.2.4. By Application
9.3.3.2.5. By End User
10. Middle East and Africa Cloning & Mutagenesis Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Gene Type
10.2.2. By Product Type
10.2.3. By Technique
10.2.4. By Application
10.2.5. By End User
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Cloning & Mutagenesis Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Gene Type
10.3.1.2.2. By Product Type
10.3.1.2.3. By Technique
10.3.1.2.4. By Application
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Cloning & Mutagenesis Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Gene Type
10.3.2.2.2. By Product Type
10.3.2.2.3. By Technique
10.3.2.2.4. By Application
10.3.2.2.5. By End User
10.3.3. UAE Cloning & Mutagenesis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Gene Type
10.3.3.2.2. By Product Type
10.3.3.2.3. By Technique
10.3.3.2.4. By Application
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Competitive Landscape
13.1. Business Overview
13.2. Product Offerings
13.3. Recent Developments
13.4. Financials (As Reported)
13.5. Key Personnel
13.6. SWOT Analysis
13.6.1. Agilent Technologies, Inc.
13.6.2. Eurofins Scientific SE
13.6.3. Sartorius AG
13.6.4. Collecta, Inc.
13.6.5. Codex DNA Inc.
13.6.6. Lonza Group AG
13.6.7. Charles River Laboratories International, Inc.
13.6.8. TransGene Biotech Co. Ltd.
13.6.9. Takara Bio, Inc.
13.6.10. Thermo Fisher Scientific Inc.
14. Strategic Recommendations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies, Inc.
  • Eurofins Scientific SE
  • Sartorius AG
  • Collecta, Inc.
  • Codex DNA Inc.
  • Lonza Group AG
  • Charles River Laboratories International, Inc.
  • TransGene Biotech Co. Ltd.
  • Takara Bio, Inc.
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Cloning and Mutagenesis Global Market Report 2024 - Product Image

Cloning and Mutagenesis Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Snyder and Champness Molecular Genetics of Bacteria. Edition No. 5. ASM Books - Product Image

Snyder and Champness Molecular Genetics of Bacteria. Edition No. 5. ASM Books

  • Book
  • 640 Pages
Molecular Biotechnology. Principles and Applications of Recombinant DNA. Edition No. 6. ASM Books - Product Image

Molecular Biotechnology. Principles and Applications of Recombinant DNA. Edition No. 6. ASM Books

  • Book
  • 896 Pages
Global Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Forecast 2024-2030 - Product Image

Global Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Molecular-Genetic and Statistical Techniques for Behavioral and Neural Research - Product Image

Molecular-Genetic and Statistical Techniques for Behavioral and Neural Research

  • Book
Copyright © 2002-2024 Research and Markets. All Rights Reserved.